Article Text

Download PDFPDF
Social distancing and cancer care during the COVID-19 pandemic
  1. Wing Lok Chan1,
  2. Pui-Ying Patty Ho2 and
  3. Kwok-Keung Yuen2
  1. 1Department of Clinical Oncology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong
  2. 2Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, Hong Kong
  1. Correspondence to Dr Wing Lok Chan, Clinical Oncology, University of Hong Kong, Hong Kong, Hong Kong; lokwingin{at}hotmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

SARS infected 1755 and killed 299 people in Hong Kong in 2003. On receiving the news of a COVID-19 outbreak in Mainland China, Hong Kong, as the closest city, was determined not to let history repeat itself. The government was quick and took major measures which included stringent border controls, health quarantine for inbound travellers, restrictions on gatherings of more than four people and so on.

In response to the pandemic threat, the hospital authority raised the emergency response level to the highest since 25 January 2020. Under this, all patient visits were suspended (with exceptional cases on compassionate grounds). Non-emergency services were deferred to …

View Full Text

Footnotes

  • Correction notice "Cambridge University Press has issued a retraction for publication of this article (Chan et al. 2020a) [https://doi.org/10.1017/S1478951521001309] . The article was simultaneously submitted and later published in BMJ Supportive & Palliative Care (Chan et al. 2020). Cambridge University Press did not have appropriate permission to publish the Accepted Manuscript version of this article. We thank Cambridge University Press for bringing this to our attention.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.